Overview

Preoperative Chemoradiation With Capecitabine and Cetuximab

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
- feasibility and tolerance of preoperative therapy with Cetuximab in combination with Capecitabine and radiotherapy for patients with locally advanced operable rectal carcinoma - collection of response rate (T-downstaging, pathological complete remission), correlation of responsiveness with EGFR-status
Phase:
Phase 2
Details
Lead Sponsor:
Austrian Breast & Colorectal Cancer Study Group
Collaborators:
Hoffmann-La Roche
Merck Gesellschaft mbH, Austria
Treatments:
Capecitabine
Cetuximab